Should You Buy Aveanna Healthcare Holdings Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Aveanna Healthcare Holdings Inc. (AVAH) occupies a solid middle-ground position with a Quality of Company score of 6.7/10. At the current market price of $14.31, the investment case depends heavily on whether our 13 independent valuation models indicate a discount to fair value.
The short answer: 1 of 9 CirclFi valuation models project upside for Aveanna Healthcare Holdings Inc. (AVAH) at $14.31 — the model consensus leans bearish, with a Quality Score of 6.7/10 and Value-Trap risk of 17/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Aveanna Healthcare Holdings Inc. (AVAH) in 2026?
What Is the Bull Case vs the Bear Case for Aveanna Healthcare Holdings Inc. (AVAH)?
| Bull case — $14.58 target (+1.9%) | Bear case — $1.54 target (-89.2%) |
|---|---|
| No active model projects meaningful upside for AVAH at $14.31. Bulls would have to argue that qualitative factors the models cannot measure will unlock value. | According to the CirclFi Deep Alpha Valuation Engine, the EROIC Spread model sees the stock as overvalued with a fair value of $1.54 (-89.2%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +91.2% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology. |
How Does AVAH Compare to Its Medical Care Facilities Peers?
Valuation data pages: CCEL · SRTA · AMN · SGRY · INNV · RHEP · ACHC · ADUS · HCSG · NHC
Which Other Stocks Score Like AVAH on Quality?
Closest companies to AVAH’s Quality of Company score of 6.7/10, across all industries.
Which Medical Care Facilities Screens Does AVAH Appear In?
So Is Aveanna Healthcare Holdings Inc. (AVAH) Worth Buying in 2026?
Our valuation engine sends a clear cautionary signal on Aveanna Healthcare Holdings Inc. at $14.31. 8/9 models flag overvaluation, median fair value sits at $7.09 (-50.5%), and the risk-reward profile appears unfavorable. Quality at 6.7/10 adds to the concern. This is a stock where patience — or avoidance — may be the optimal strategy.
These are quantitative model outputs, not investment recommendations. Aveanna Healthcare Holdings Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About AVAH Stock?
Should I buy AVAH stock right now?
Based on CirclFi's multi-model analysis, 1 of 9 models see upside for AVAH at $14.31. The models are divided, which means the investment case depends heavily on your assumptions about Aveanna Healthcare Holdings Inc.'s future. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Aveanna Healthcare Holdings Inc.?
Key risks include: wide model disagreement (847% spread), signaling high uncertainty; general market and sector-specific risks affecting Medical Care Facilities companies. Always diversify and consult a financial advisor.
How does AVAH compare to its competitors?
Among Medical Care Facilities peers, AVAH holds a Quality Score of 6.7/10. Comparable companies include CCEL (QOC 6.7), SRTA (QOC 6.5), AMN (QOC 6.7). The relative ranking helps investors identify whether AVAH offers better fundamental quality than alternatives in the same sector.
Is AVAH a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. AVAH's Quality Score of 6.7/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.
What price should I buy AVAH at?
CirclFi does not provide target buy prices or price alerts. However, our 9 active models produce fair value estimates ranging from $1.54 to $14.58. At $14.31, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for AVAH.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad